Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Taking the contraceptive pill may reduce the risk of developing cancer

Taking the contraceptive pill may reduce the risk of developing cancer

September 12, 2007

Cancer risk among users of oral contraceptives: cohort data from the Rotal College of General Practitioner's oral contraception study

Taking the contraceptive pill does not increase a woman's chances of developing cancer and may even reduce the risk for most women, according to a study published on bmj.com today.




However, there was an increased risk for women who used it for more than 8 years.

Since its introduction in the early 1960s, more than 300 million women are thought to have used oral contraception. Although several studies have looked at the overall balance of cancer deaths associated with oral contraceptives, none have so far examined the absolute risks or benefits.

Researchers from the University of Aberdeen analysed data spanning a 36 year period from the Royal College of General Practitioners (RCGP) Oral Contraception Study which began in 1968. The study recruited 46,000 women, with an average age of 29. Approximately half were using oral contraceptives; the other half had never taken it. Every six months their GP provided the study with information on the women's health. In addition, three quarters of the women were 'flagged' at the NHS central registries so that deaths and cancers were notified to the study even if women had left their recruitment GP.

Professor Philip Hannaford and colleagues used the data to calculate the risk of developing any type of cancer and the main gynaecological cancers combined. They also considered the effects of variables such as age, smoking and social class.

Given the length of the study a significant number of GPs had not been able to provide updates throughout the entire study period, for example if a woman moved out of the area of their doctor. So Professor Hannaford and colleagues from the University of Aberdeen's Department of General Practice and Primary Care calculated the cancer risks using two sets of data. One that related to cancers reported while the women remained registered with their recruiting GP and whose information was more detailed (GP observation dataset) The second main study dataset which was larger, also included cancers notified by the central NHS registries after women had left their recruiting GP.

In both data sets there was no overall increased risk of cancer among pill users. When the GP observation dataset was used, women who had taken the pill at some time during their lives had a 3% reduced risk of developing any cancer. When the larger main dataset was used, the reduction was 12%. A 12% reduction equates to approximately one fewer case of cancer for every 2,200 women who have used the pill for a year and 3% equates to one fewer case of cancer for every 10,000 women. In the main dataset women on the pill had statistically significant lower rates of large bowel/rectal, uterine body and ovarian cancer. The GP dataset also showed a reduced risk of uterine and ovarian cancer.

The researchers did sound a note of caution. When the women were examined by how long they had used the pill, women who used it for more than 8 years - less than a quarter of pill users in the study - had a statistically significant increased risk of developing any cancer, in particular cervical and central nervous system cancer. However the same women were at reduced risk of developing ovarian cancer. Evidence suggests that the protective effect of taking the pill lasts for at least 15 years after stopping.

The authors say that many women, especially those who used the first generation of oral contraceptives many years ago, are likely to find the results reassuring:

"In this UK cohort oral contraception was not associated with an overall increased risk of any cancer, indeed it may even produce a net public health gain.

BMJ-British Medical Journal



Related Oral Contraceptive Current Events and Oral Contraceptive News Articles Oral Contraceptive Current Events and Oral Contraceptive News RSS Oral Contraceptive Current Events and Oral Contraceptive News RSS
Study explains potential failure of oral contraceptives with obese women
Researchers have identified a potential biological mechanism that could explain why oral contraceptives may be less effective at preventing pregnancy in obese women, as some epidemiological studies have indicated.

2 reproductive factors are important predictors of death from ovarian cancer
Researchers from the Centers for Disease Control and Prevention (CDC) found that survival among women with ovarian cancer is influenced by age of menarche and total number of lifetime ovulatory cycles.

Contraceptive use may be safe, but information gaps remain
Introduced in the 1960s, oral contraceptives have been used by about 80 percent of women in the United States at some point in their lives.

Birth control has long-term effect on hormone exposure
Researchers at Wake Forest University School of Medicine may be one step closer to understanding why past oral contraceptive use dramatically lowers the risk of ovarian and uterine cancers later in life.

Study identifies trends of vitamin B6 status in US population sample
In an epidemiological study, Tufts University researchers identified trends of vitamin B6 status in a sample of the United States population based on measures of plasma pyridoxal 5'- phosphate (PLP) levels in the bloodstream. Plasma PLP is the indicator used by the federal government to set the current Recommended Dietary Allowance (RDA) of vitamin B6, a nutrient essential for red blood cell function and important for maintaining a healthy immune system and blood glucose levels.

Hormone use related to lower risk of macular degeneration in postmenopausal women
Women who take postmenopausal hormones appear to have a lower risk of developing advanced stages of the eye disease age-related macular degeneration, especially if they had also taken oral contraceptives in the past, according to a report in the April issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

May inflammatory bowel disease mimic gynecological disorders in its clinical presentation
Endometriosis is a condition of unknown etiology in which endometrial tissue occurs at extra-uterine sites, including ovaries, fallopian tubes, and gastrointestinal tract.

Texas A&M testing oral contraceptives for animals
If you're a land owner and animals such as coyotes or wild pigs are driving you hog wild, help may soon be on the way to control their numbers in a humane way - in the form of a birth control pill for animals being developed at Texas A&M University's College of Veterinary Medicine & Biomedical Sciences.

Differing attitudes found between women and doctors concerning menstrual suppression
More than the two thirds of the women in a national survey say that they are interested in suppressing their menstrual periods but many of them aren't sure if it's safe.

HPV vaccine does not appear to be effective for treating pre-existing HPV infection
For women with human papillomavirus (HPV) infection, use of the HPV-16/18 vaccine will not accelerate reduction of the virus and should not be used to treat the infection, according to a study in the August 15 issue of JAMA.
More Oral Contraceptive Current Events and Oral Contraceptive News Articles
  Managing Contraceptive Pill Patients
by Richard P. Dickey (Author)

Louisiana State Univ., New Orleans. Contains most of the known oral contraceptive (OC) side effects and their causes with a recommended plan of management. Tables list categorical activities of OCs. Intended to help clinicians choose among OC types. Trim size: 7.5 x 4.25 inches. Softcover.

On the Pill: A Social History of Oral Contraceptives, 1950-1970

On the Pill: A Social History of Oral Contraceptives, 1950-1970
by Elizabeth Siegel Watkins (Author)

"In 1968, a popular writer ranked the pill's importance with the discovery of fire and the developments of tool-making, hunting, agriculture, urbanism, scientific medicine, and nuclear energy. Twenty-five years later, the leading British weekly, the Economist, listed the pill as one of the seven wonders of the modern world. The image of the oral contraceptive as revolutionary persists in popular culture, yet the nature of the changes it supposedly brought about has not been fully investigated. After more than thirty-five years on the market, the role of the pill is due for a thorough examination."—from the Introduction

In this fresh look at the pill's cultural and medical history, Elizabeth Siegel Watkins re-examines the scientific and ideological forces that led to its...

OC Companion / 60 caps

OC Companion / 60 caps
by Vitanica

Oral contraceptives have been shown to lower the levels of six nutrients: riboflavin, B6, folic acid, vitamin B12, ascorbic acid and zinc. This formula was designed to provide selective nutritional support, promote enhanced hormonal metabolism and strengthen detoxification pathways.* Each vegetarian suitable capsule includes: Vitamin A (as Betatene®, natural mixed carotenoids), Vitamin C (as calcium ascorbate), Vitamin E (as d-alpha tocoperyl succinate), Vitamin B2 (as riboflavin), Vitamin B6 (as pyridoxal-5-phosphate), Folate (as folic acid), Vitamin B12 (as methylcobalamin), Zinc (as picolinate), Copper (as gluconate), DIM (Diindolymethane), Bromelain, L. acidolphilus, Dandelion root ~ Taraxacum officinale, Borage oil powder (8% GLA), Garlic (10,000 ppm allicin potential)

Summary of Drug Interactions with Oral Contraceptives (Summary of Oral Contraceptive Data Series)

Summary of Drug Interactions with Oral Contraceptives (Summary of Oral Contraceptive Data Series)
by T.B.P. Geurts (Author), E.M. Goorissen (Author)

This volume is designed to help physicians in their daily practice by providing practical information in an accessible form. When prescribing drugs the physician has to take into consideration that concurrent administration may lead to drug interactions. This is especially so in the case of oral contraceptives, which are agents usually taken continuously for many years. Interactions due to the concurrent administration of an oral contraceptive and another drug may have two different implications - either reduced efficacy of the pill, or an altered pharmacological effect of the other drug (and, occasionally, as a result of the latter, even the occurence of adverse effects). Both types of interactions are reviewed. A systematic, classified approach is used throughout the text. Individual...

Sexual Chemistry: A History of the Contraceptive Pill

Sexual Chemistry: A History of the Contraceptive Pill
by Dr. Lara V. Marks (Author)

Heralded as the catalyst of the sexual revolution and the solution to global overpopulation, the contraceptive pill was one of the twentieth century's most important inventions. It has not only transformed the lives of millions of women but has also pushed the limits of drug monitoring and regulation across the world. This deeply- researched new history of the oral contraceptive shows how its development and use have raised crucial questions about the relationship between science, medicine, technology, and society.

Lara Marks traces the scientific origins of the pill to Europe and Mexico in the early years of the twentieth century, challenging previous accounts that championed it as a North American product. She explores the reasons why the pill took so long to be ...

Summary of Contraindications to Oral Contraceptives

Summary of Contraindications to Oral Contraceptives
by S. C. M. Knijff (Author), E. M. Goorissen (Author), E. J. M. Velthuis-Te Wierik (Author), T. Korver (Author), David A. Grimes (Author)

This volume comprehensively summarizes all contraindications to oral contraceptives. It contains more than 90 individual chapters and topic-specific addenda in ten sections opening with general information on the safety of the pill, medical conditions, the literature and studies and epidemiological principles. The main sections of the book cover contraindications, the circulatory system, thromboembolic risk, the hemostasis system, risk factors for circulatory disease, the contraindication status of potentially relevant disorders, malignant conditions of the genital organs, severe diseases of the liver and biliary system, and a wide range of other conditions. Includes bibliographic references and index.

GLYDE Flavored Dental Dams: 3 units.

GLYDE Flavored Dental Dams: 3 units.
by Global Protection

Protect yourself and your partner during oral encounters with these flavored dental dams. Each 10" x 6" sheet comes in a variety of flavors, including VANILLA, WILDBERRY, STRAWBERRY, and COLA Don't forget the importance of oral safety with these FDA approved oral dams

Extragenital Effects of Oral Contraceptives

Extragenital Effects of Oral Contraceptives
by M. Elstein (Editor)

This is a compact scientific monograph on the extragenital effects of a combined formulation of ethinylestradiol at an acceptable dose of 30 µg and the new progestogen, dienogest. The book contains five main chapters on cardiovascular risks, ideal doses, clinical experiences, and hormonal control of androgenic disorders in women. The studies reported in this volume are of special interest to practitioners and researchers because in clinical trials this new formulation has provided reliable contraceptive action with good cycle control and a high level of acceptability. These studies lend support to expectations derived from the basic pharmacological experimentations, mostly animal-based, showing that the new progestogen does not interfere with the metabolism of ethinylestradiol in the...

  OCs pose risk in women with migraine/aura.(News)(oral contraceptives): An article from: Internal Medicine News
by Sharon Worcester (Author)

This digital document is an article from Internal Medicine News, published by Thomson Gale on April 1, 2007. The length of the article is 594 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: OCs pose risk in women with migraine/aura.(News)(oral contraceptives)
Author: Sharon Worcester
Publication: Internal Medicine News (Magazine/Journal)
Date: April 1, 2007
Publisher: Thomson Gale
Volume: 40 Issue: 7 Page: 7(1)

Distributed by Thomson...

Submaximal Cycle Ergometry as a Predictor of Maximal Aerobic Capacity inWomen on Oral Contraceptives

Submaximal Cycle Ergometry as a Predictor of Maximal Aerobic Capacity inWomen on Oral Contraceptives
by Jannell C. MacAulay (Author)

This is a AIR FORCE INST OF TECH WRIGHT-PATTERSONAFB OH report procured by the Pentagon and made available for public release. It has been reproduced in the best form available to the Pentagon. It is not spiral-bound, but rather assembled with Velobinding in a soft, white linen cover. The Storming Media report number is A432073. The abstract provided by the Pentagon follows: Predicted maximal aerobic capacity (VO2max), using submaximal exercise tests, is used to evaluate fitness for job performance, especially within the military. Women who use oral contraceptives experience a rhythmic variation of circulating synthetic hormones that can influence submaximal exercising heart rate. The purpose of this study was to examine the validity and reliability of two submaximal heart...

© 2009 BrightSurf.com